Drug Guide

Generic Name

Protein Hydrolysate

Brand Names Aminosol 5%, Hyprotigen 5%

Classification

Therapeutic: Nutritional supplement, Parenteral nutrition adjunct

Pharmacological: Amino acid preparation derived from protein hydrolysis

FDA Approved Indications

Mechanism of Action

Provides free amino acids derived from hydrolyzed proteins, which are utilized by the body for protein synthesis and metabolic functions.

Dosage and Administration

Adult: By infusion, dose individualized based on nutritional requirements; common starting concentration is 5%.

Pediatric: Dose based on age, weight, and clinical condition; typically administered via infusion similar to adult protocols.

Geriatric: Adjust dose considering renal and hepatic function; monitor for fluid overload.

Renal Impairment: Dose adjustment may be necessary; monitor renal function.

Hepatic Impairment: Use caution; monitor liver function and nutritional status.

Pharmacokinetics

Absorption: Not applicable; administered intravenously.

Distribution: Distributed throughout body water compartments.

Metabolism: Utilized directly for protein synthesis or converted into energy.

Excretion: Metabolized into urea and other nitrogenous waste products primarily via kidneys.

Half Life: Dependent on administered dose and patient’s metabolic rate.

Contraindications

Precautions

Adverse Reactions - Common

Adverse Reactions - Serious

Drug-Drug Interactions

Drug-Food Interactions

Drug-Herb Interactions

Nursing Implications

Assessment: Monitor fluid status, electrolyte balance, renal and liver function, and for signs of allergic reaction.

Diagnoses:

  • Imbalanced nutrition: less/more than body requirements
  • Risk for fluid overload
  • Risk for allergic reaction

Implementation: Administer via appropriate infusion pump, monitor sites, and adjust infusion rate as needed.

Evaluation: Adequacy of nutritional intake, absence of adverse reactions, normal laboratory parameters.

Patient/Family Teaching

Special Considerations

Black Box Warnings:

Genetic Factors: Genetic polymorphisms generally do not affect its use.

Lab Test Interference: May affect nitrogen balance measurements.

Overdose Management

Signs/Symptoms: Potential fluid overload, electrolyte imbalance, allergic reactions.

Treatment: Discontinue infusion, support respiratory and cardiovascular functions as needed, and treat symptoms accordingly.

Storage and Handling

Storage: Store at controlled room temperature, protected from light and moisture.

Stability: Use within the manufacturer’s specified period after reconstitution or opening.

This guide is for educational purposes only and is not intended for clinical use.